packageGemtuzumabOzogamicin

gemtuzumab ozogamicin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Gemtuzumab ozogamicin is an antibody-drug conjugate used to treat acute myeloid leukemia. It is authorised in the European Union and carries a boxed warning, so its use is closely monitored.

Summary written by glm-5.3-flash from Wikidata Q412685 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:gemtuzumab ozogamicin
ATC codes:L01FX02, L01XC05
DrugBank:DB00056
Wikidata:Q412685
molar mass:151500 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown